73.45MMarket Cap-3992P/E (TTM)
5.638High5.420Low49.59KVolume5.460Open5.390Pre Close274.30KTurnover0.37%Turnover RatioLossP/E (Static)13.33MShares6.97052wk High1.91P/B73.17MFloat Cap3.40052wk Low--Dividend TTM13.28MShs Float141.000Historical High--Div YieldTTM4.04%Amplitude2.510Historical Low5.531Avg Price1Lot Size
enVVeno Medical Stock Forum
enVVeno Medical Provides Update on FDA Premarket Approval Application Status for VenoValve(R)
enVVeno Medical has made significant progress in its FDA premarket approval (PMA) application for the VenoValve, a surgical replacement venous valve. The company has successfully submitted, and the FDA has approved, four out of five modules required for the PMA application. The fifth and final module, containing clinical data from the SAVVE U.S. pivotal trial, is expecte...
New Interim Venous Ulcer Healing Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the Society for Vascular Surgery 2024 Vascular Annual Meeting on June 21, 2024
enVVeno Medical announced the presentation of new interim venous ulcer healing data from the VenoValve U.S. pivotal trial at the Society for Vascular Surgery 2024 Vascular Annual Meeting on June 21, 2024. The data, presented by Dr. Cassius Iyad Ochoa Chaar of Yale School of Medici...
No comment yet